MM
Therapeutic Areas
MARAbio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MAR-Autism Diagnostic Test | Risk assessment for Maternal Autoantibody Related Autism (MARA) | Commercial |
| Proprietary Therapeutic Antibody Interventions | Mitigation of Maternal Autoantibody Related Autism (MARA) | Pre-clinical |
Leadership Team at MARAbio
MS
Michael S. Paul, PhD
Chief Executive Officer & President
JV
Judy Van de Water, PhD
Founder, Chief Science Advisor
ER
E. Robert Wassman, MD
Chief Medical Officer, EVP of Clinical Affairs
JN
James N. Woody, MD, PhD
Chief Science Officer
VA
Vincent A. Forlenza, MBA
Chairman, Board of Directors